Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ychou

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumorsS Culine, M Fabbro, C Assens, et al.
Annales De Chirurgie|January 1, 1994
[Proctectomy and colo-anal anastomosis after high-dose irradiation of cancers of the lower third of the rectum. Functional and oncological results]P Rouanet, F Dravet, J B Dubois, et al.
Anticancer Research|July 1, 1997
Pharmacokinetics of 5-fluorouracil (5-FUra) in patients with metastatic colorectal cancer receiving 5-FUra bolus plus continuous infusion with high dose folinic acid (LV5FU2)J M Joulia, F Pinguet, M Ychou, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 1, 2005
[Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice]D Azria, M Coelho, C Larbouret, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 19, 2010
[Histologic assessment of treatment effect of preoperative chemoradiation in patients presenting with resectable pancreatic adenocarcinoma]R Le Scodan, F Mornex, C Partensky, et al.
British Journal of Cancer|June 16, 2005
p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysisE Lopez-Crapez, F Bibeau, S Thézenas, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 4, 2012
Survey on the management of skin toxicity associated with EGFR inhibitors amongst French physiciansL Peuvrel, C Bachmeyer, Z Reguiai, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 11, 2010
Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic responseO Turrini, M Ychou, L Moureau-Zabotto, et al.
Oncology|January 11, 2008
Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French settingJ Y Douillard, P Tilleul, M Ychou, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 25, 2012
Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitorsL Peuvrel, C Bachmeyer, Z Reguiai, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumorsS Culine, M Fabbro, C Assens, et al.
Annales De Chirurgie|January 1, 1994
[Proctectomy and colo-anal anastomosis after high-dose irradiation of cancers of the lower third of the rectum. Functional and oncological results]P Rouanet, F Dravet, J B Dubois, et al.
Anticancer Research|July 1, 1997
Pharmacokinetics of 5-fluorouracil (5-FUra) in patients with metastatic colorectal cancer receiving 5-FUra bolus plus continuous infusion with high dose folinic acid (LV5FU2)J M Joulia, F Pinguet, M Ychou, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 1, 2005
[Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice]D Azria, M Coelho, C Larbouret, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 19, 2010
[Histologic assessment of treatment effect of preoperative chemoradiation in patients presenting with resectable pancreatic adenocarcinoma]R Le Scodan, F Mornex, C Partensky, et al.
British Journal of Cancer|June 16, 2005
p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysisE Lopez-Crapez, F Bibeau, S Thézenas, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 4, 2012
Survey on the management of skin toxicity associated with EGFR inhibitors amongst French physiciansL Peuvrel, C Bachmeyer, Z Reguiai, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 11, 2010
Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic responseO Turrini, M Ychou, L Moureau-Zabotto, et al.
Oncology|January 11, 2008
Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French settingJ Y Douillard, P Tilleul, M Ychou, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 25, 2012
Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitorsL Peuvrel, C Bachmeyer, Z Reguiai, et al.
Pageof 11